Industry | 2021.07.24
Global Biosimilar Monoclonal Antibodies (mAbs) Market in Pharmaceuticals Industry|Discover Company Insights in Technavio
NEW YORK, July 23, 2021 /PRNewswire/ -- The biosimilar monoclonal antibodies (mAbs) market is poised to grow by USD 3.48 billion during 2021-2025, progressing at a CAGR of 14.05% during the forecast period. Here is an Exclusive report talking about Market scenarios, Estimates, the impact...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ts-in-technavio-301340099.html
